Selective COX-2 inhibitor continues to be a safe alternative in patients with nonselective NSAIDs hypersensitivity.
Qatar Med J
; 2022(2): 4, 2022.
Article
en En
| MEDLINE
| ID: mdl-35968519
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
Idioma:
En
Año:
2022
Tipo del documento:
Article